| Financial Year |
March 31 2023 |
| Monetary Funds |
541,686,488.76 |
| Held-for-trading Financial Assets |
50,773,457.87 |
| Notes Receivable |
138,942,186.88 |
| Accounts Receivable |
576,404,448.58 |
| Advances to Suppliers |
28,372,582.25 |
| Other Receivables |
16,221,226.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
470,693,653.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
217,111,389.03 |
| Total Current Assets |
2,141,571,390.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
66,728,822.10 |
| Investment Properties |
13,763,993.12 |
| Fixed Assetes |
587,109,685.33 |
| Under-construction Projects |
244,443,846.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
139,258,488.63 |
| R&D expenses |
-- |
| Goodwill |
34,933,593.16 |
| Long-Term Deferred and Prepaid Expenses |
17,394,941.98 |
| Deferred Income Tax Assets |
42,909,456.37 |
| Other Non-Current Assets |
29,441,547.72 |
| Sub-Total of Non-Current Assets |
1,321,152,192.62 |
| Total Assets |
3,462,723,583.07 |
| Short-Term Loans |
623,691,308.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
429,168,607.86 |
| Accounts Payable |
323,708,918.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,223,071.84 |
| Taxes Payable |
13,121,093.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,291,886.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,456,288.57 |
| Other Current Liabilities |
4,254,533.91 |
| Sub-Total of Current Liabilities |
1,513,872,667.48 |
| Long-term Loans |
138,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
329,131.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
215,715,464.27 |
| Total Liabilities |
1,729,588,131.75 |
| Paid-In Capital(Or Share Stock) |
263,741,550.00 |
| Capital Surplus |
810,630,915.07 |
| Surplus Reserve |
45,802,401.95 |
| LESS:Treasury Stock |
30,932,646.72 |
| Undistributed Profits |
554,614,110.26 |
| Minority Stockholder's Interest |
43,787,332.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,689,348,118.76 |
| Owner's Equity（Stockholder's Equity） |
1,733,135,451.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,462,723,583.07 |
